Psychiatric Medication Use Associated with Triple the Risk of Stroke
Common psychiatric medications double the risk of heart attack and triple the risk of stroke, according to research presented at the Canadian Cardiovascular Congress...
No Good Evidence That Antidepressants Prevent Relapse
Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.
How Providers Can Support Psychiatric Drug Discontinuation
Supportive patient-practitioner relationships are crucial to the successful discontinuation of psychiatric medication.
Children on Antipsychotics 50% More Likely to Develop Diabetes
Antipsychotic drugs increased the risk of children developing diabetes by 50%, and with an antidepressant added, their risk doubled.
Evidence Lacking for Antidepressant Safety in Nursing Mothers
A scientific review says we need to know much more about the risks of nursing mothers taking SSRIs.
Differentiation of SSRI and Benzo Dependence/Withdrawal “Not Rational”
Researchers from the Cochrane Center and University of Copenhagen in Denmark, publishing in the May issue of Addiction, "explore the rationale for claiming that...
Internet Forum for Tapering Psychiatric Drugs Provides Novel Insights
After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.
New Guidance on Antidepressant Withdrawal for Doctors in the UK
New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.
Antipsychotic Drug Associated with Potentially Fatal Skin Rash
The US Food and Drug Administration is warning the public that the antipsychotic medication ziprasidone "is associated with a rare but serious skin reaction...
Antidepressant Withdrawal Symptoms Linked to Life-Altering Consequences, New Study Shows
A new study reveals that withdrawal symptoms from antidepressants can last years, disrupting lives and relationships.
Researchers: Antidepressant Withdrawal, Not “Discontinuation Syndrome”
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Neuroleptic Drugs and Violence
Neuroleptic Drugs and Violence
by
Catherine Clarke SRN, SCM, MSSCH, MBChA.
and Jan Evans MCSP. Grad Dip Phys.
Cognitive Function Improved by Reducing Antipsychotics
A 28-week randomized controlled study by researchers in Japan, Canada and the United States finds that a 50% reduction of risperidone or olanzapine significantly...
PTSD and Antidepressants Linked to Diabetes
A JAMA Psychiatry study found links between PTSD, type 2 diabetes, and antidepressants.
Four Essential Studies on Antidepressant Withdrawal Every Prescriber Must Read
A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.
Antipsychotics Again Strongly Linked to Falls and Fractures
Three independent studies in two journals reported strong links between antipsychotics and falls and fractures.
How to Distinguish Antidepressant Withdrawal from Relapse
Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.
Over One Thousand Boys Grew Breasts “Probably” Caused By Common Psychiatric Medication
According to an ex-chief of the FDA, Johnson & Johnson knew long before it started warning people that Risperdal could cause boys to grow breasts.
The Ethics of Antipsychotic Dose Reduction and Patient Rights
New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.
J&J Loses Case Over Risperdal Antipsychotic Causing Male Breast Growth
A jury decided Johnson & Johnson must pay a Philadelphia man $2.5 million in damages "for failing to warn that its Risperdal antipsychotic could cause gynecomastia."
Gradual Tapering is Most Successful for Withdrawal from Antipsychotics
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
New Clinical Guidelines on Deprescribing Benzodiazepines
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
New Antidepressant Shows Little Benefit, Significant Risks
Patient Drug News advises avoiding use of the antidepressant Vortioxetine (also called Brintellix or Trintellix), because the most recent evidence from the FDA shows...
SSRI Withdrawal has Social, Cognitive, and Emotional Consequences
New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.
“Serious Breakdown” on Cymbalta Withdrawal Warnings
"The last four years have seen a 90% increase in the number of serious adverse drug reports received by the Food and Drug Administration," according to a report by the Institute for Safe Medication Practices." Among them, a "signal" that Cymbalta causes "an array of problems such as crying, suicidal ideation, and anger, and other symptoms including effects on appetite and weight gain."
